Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy

BACKGROUND: Thus far, few studies have investigated the safety and efficacy of programmed death-1 (PD-1) immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) antibodies in patients with hepatitis B virus (HBV)-related liver cancer. OBJECTIVE: To investigate the effect of combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Shida, Yu, Yingying, Wang, Siyu, Tu, Bo, Shen, Yingjuan, Qiu, Qin, Liu, Xiaomeng, Su, Nan, Zuo, Yanmei, Luan, Junqing, Zhang, Ji−Yuan, Shi, Ming, Meng, Fanping, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195870/
https://www.ncbi.nlm.nih.gov/pubmed/35711409
http://dx.doi.org/10.3389/fimmu.2022.892618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195870/
https://www.ncbi.nlm.nih.gov/pubmed/35711409
http://dx.doi.org/10.3389/fimmu.2022.892618

Ejemplares similares